CD40 ligand (CD154) takes part in regulation of the transition to mononuclear cell dominance during peritonitis

Kidney International

Volumn 67, Issue 4, 2005, Pages 1340-1349

  Mazar, Julia ^a   Agur, Timna ^a   Rogachev, Boris ^a   Ziv, Nadav Yehuda ^a   Zlotnik, Moshe ^a   Chaimovitz, Cidio ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CD154; CD40; Chemokines; Leukocyte recruitment; Peritonitis

Indexed keywords

BETA CHEMOKINE; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL INFILTRATION; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LEUKOCYTE MIGRATION; LIGAND BINDING; MESOTHELIUM CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 16244408931     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00211.x     Document Type: Article

References (31)

1. GREWAL IS, FLAVELL RA: CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135, 1998
2. VAN KOOTEN C, BANCHEREAU J: CD40-CD40 ligand. J Leukoc Biol 67:2-17, 2000
3. SCHONBECK U, MACH F, LIBBY P: CD154 (CD40 ligand). Int J Biochem Cell Biol 32:687-693, 2000
4. YAMADA A, SAYEGH MH: The CD154-CD40 costimulatory pathway in transplantation. Transplantation 73:S36-S39, 2002
5. ADAWI A, ZHANG Y, BAGGS R, et al: Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. Clin Immunol Immunopathol 89:222-230, 1998
6. HOWARD LM, MIGA AJ, VANDERLUGT CL, et al: Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103:281-290, 1999
7. LUTGENS E, DAEMEN MJ: CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 12:27-32, 2002
8. WOODROW G, TURNEY JH, BROWNJOHN AM: Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 17:360-364, 1997
9. VARGEMEZIS V, THODIS E: Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 16:106-108, 2001
10. MIYATA T, DEVUYST O, KUROKAWA K, VAN YPERSELE DE STRIHOU C: Toward better dialysis compatibility: Advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 61:375-386, 2002
11. MATEIJSEN MA, VAN DER WAL AC, HENDRIKS PM, et al: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
12. HAUSMANN MJ, ROGACHEV B, WEILER M, et al: Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int 57:476-486, 2000
13. TOPLEY N, JORRES A, LUTTMANN W, et al: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1 beta and TNF alpha. Kidney Int 43:226-233, 1993
14. DOUVDEVANI A, RAPOPORT J, KONFORTY A, et al: Human peritoneal mesothelial cells synthesize IL-1 alpha and beta. Kidney Int 46:993-1001, 1994
15. LI FK, DAVENPORT A, ROBSON RL, et al: Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 54:2170-2183, 1998
16. JONJIC N, PERI G, BERNASCONI S, et al: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176:1165-1174, 1992
17. ZEILLEMAKER AM, MUL FP, HOYNCK VAN PAPENDRECHT AA, et al: Polarized secretion of interleukin-8 by human mesothelial cells: A role in neutrophil migration. Immunology 84:227-232, 1995
18. HURST SM, WILKINSON TS, MCLOUGHLIN RM, et al: II-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705-714, 2001
19. BASOK A, SHNAIDER A, MAN L, et al: CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 12:695-702, 2001
20. MAN L, LEWIS E, EINBINDER T, et al: Major involvement of CD40 in the regulation of chemokine secretion from human peritoneal mesothelial cells. Kidney Int 64:2064-2071, 2003
21. ROBSON RL, MCLOUGHLIN RM, WITOWSKI J, el al: Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-gamma controls neutrophil migration across the mesothelium in vitro and in vivo. J Immunol 167:1028-1038, 2001
22. YANG X, YE RG, KONG QY, et al: CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 16:213-215, 2000
23. MUNOZ DE BUSTILLO E, AGUILERA A, JIMENEZ C, et al: Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study. Perit Dial Int 17:392-395, 1997
24. FRIED L, PIRAINO B: Peritonitis, in Textbook of Peritoneal Dialysis, 2nd ed., edited by Gokal R, Khanna R, Krediet RT, Nolph KD, Dordrecht, Kluwer Academic Publisher, 2000, pp 545-562
25. TOPLEY N: The cytokine network controlling peritoneal inflammation. Perit Dial Int 15:S35-S39, 1995
26. TOPLEY N, LIBEREK T, DAVENPORT A, et al: Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int (Suppl 56):S17-S21, 1996
27. FAULL RJ: Peritoneal defenses against infection: Winning the battle but losing the war? Semin Dial 13:47-53, 2000
28. MONK NJ, HARGREAVES RE, MARSH JE, et al: Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med 9:1275-1280, 2003
29. KOTOWICZ K, DIXON GL, KLEIN NJ, et al: Biological function of CD40 on human endothelial cells: Costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 100:441-448, 2000
30. MACH F, SCHONBECK U, SUKHOVA GK, et al: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203, 1998
31. KALLED SL, CUTLER AH, DATTA SK, THOMAS DW: Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function. J Immunol 160:2158-2165, 1998